Prodrugs of modulators of the NMDA receptor
Abstract:
The present invention is directed to novel prodrugs of modulators of the NMDA receptor. Separate aspects of the inventions are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat neurological disorders or neuropsychiatric disorders such as depression.
Public/Granted literature
Information query
Patent Agency Ranking
0/0